weight loss drugs other than glp-1 List of approved and pending medications Compound versions of GLP-1 drugs
Description
In 2025, it initially had the same sales forecast as for this year, but upgraded it twice
Last reviewed: June 1, 2026 Last updated: June 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
To view or add a comment, sign in GLP-1 medicines represent a significant advancement in the treatment of obesity and food-related illnesses
Tirzepatide (Mounjaro, Zepbound) is a related but distinct medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
Strengths and limitations Our study had several strengths
